Biotechnology
Investors see growth opportunity in Femtech devoted to women’s health
To Dr. Connie Lehman, a breast cancer scan is like a fingerprint that provides clues for developing personalized medical care. “There is so much information in every digital image of a woman’s breast tissue, and the deep learning technology can extract that and predict the future and in ways we haven’t been able to […]
Read More
Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | Pool | Reuters Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase […]
Read More
Merck’s Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24%
Stefanie Joho, 27, stands for a portrait at the home of a friend in Penn Valley, PA on Tuesday, May 9, 2017. Joho, who was diagnosed with colon cancer at 22 years old, has been in remission since February 2016, thanks to an immunotherapy drug targeted at specific mutations that prevents repair of DNA-replication mistakes. […]
Read More
Biden names Dr. Ashish Jha new Covid response coordinator to succeed Jeff Zients
Dr. Ashish Jha is pictured in Providence, RI on Dec. 3, 2020. Jonathan Wiggs | Boston Globe | Getty Images President Joe Biden on Thursday named Dr. Ashish Jha as his new Covid-19 response coordinator to succeed Jeff Zients, who served in the role through the delta and omicron surges. Jha leads Brown University’s School […]
Read More
Moderna CEO Stephane Bancel has sold more than $400 million of company stock during the pandemic
Moderna CEO Stephane Bancel Steven Ferdman | Getty Images Moderna CEO Stephane Bancel has sold $408 million in company stock since the beginning of the coronavirus pandemic — averaging roughly $3.6 million a week — as the company’s stock soared on the development and rollout of its Covid vaccine, according to CNBC’s analysis of the […]
Read More
Pfizer to seek authorization for 2nd Covid booster for people 65 and older
A medical staff prepares a booster dose of Pfizer’s coronavirus disease (COVID-19) vaccine are seen at a vaccination centre in Brussels, Belgium, January 5, 2022. Yves Herman | Reuters Pfizer and BioNTech are expected to seek U.S. authorization this week for a second Covid-19 vaccine booster for people 65 and older, according to a person […]
Read More
White House says U.S. will run out of money to fight pandemic if Congress doesn’t pass Covid funding bill
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The White House on Tuesday warned the U.S. won’t have enough booster shots and lifesaving Covid treatments for Americans if […]
Read More
Leaders of NATO countries discuss plans to meet in Brussels next week, officials say
A view of a meeting of the North Atlantic Council (NAC) at the level of Foreign Ministers gather at the NATO Headquarters in Brussels, March 4, 2022. Olivier Douliery | Reuters The heads of state representing NATO’s 30 member countries are discussing meeting in person in Brussels next week as Russia’s invasion of Ukraine reaches […]
Read More
Vaccine maker stocks rise as China battles worst Covid outbreak since 2020
Shares of the major vaccine makers rose on Monday as China battles its worst Covid outbreak since 2020, fueling fear that the pandemic will drag on which could drive demand for future vaccine orders. Moderna‘s stock jumped more than 8% to close at $150.07. In the morning, the biotech company’s stock had surged nearly 20% […]
Read More
Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants
Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC on Friday. “I think we’re going to submit to FDA a significant progress of data about the need for a fourth […]
Read More